Latest news with #votingRights
Washington Post
10 hours ago
- General
- Washington Post
Supreme Court will consider reviving Republican challenge to Illinois law on mail ballots
WASHINGTON — The Supreme Court agreed Monday to consider reviving a Republican challenge to an Illinois law that allows mail ballots to be counted if they are received up to two weeks after Election Day. The justices will hear arguments in the fall over whether Rep. Mike Bost, R-Ill., and two former presidential electors have the legal right, or standing, to sue over the law in federal court. Lower federal courts ruled they lack standing. But the case could serve to amplify claims made by President Donald Trump that late-arriving ballots and drawn out electoral counts undermine confidence in elections. Illinois is among 18 states and the District of Columbia that accept mailed ballots received after Election Day as long they are postmarked on or before that date, according to the National Conference of State Legislatures. In March, Trump signed a sweeping executive order on elections that aims to require votes to be 'cast and received' by Election Day and says federal funding should be conditional on state compliance. In their appeal to the court, the Illinois Republicans said the justices should make clear that candidates have the right to challenge state regulations of federal elections.
Associated Press
10 hours ago
- General
- Associated Press
Supreme Court will consider reviving Republican challenge to Illinois law on mail ballots
WASHINGTON (AP) — The Supreme Court agreed Monday to consider reviving a Republican challenge to an Illinois law that allows mail ballots to be counted if they are received up to two weeks after Election Day. The justices will hear arguments in the fall over whether Rep. Mike Bost, R-Ill., and two former presidential electors have the legal right, or standing, to sue over the law in federal court. Lower federal courts ruled they lack standing. But the case could serve to amplify claims made by President Donald Trump that late-arriving ballots and drawn out electoral counts undermine confidence in elections. Illinois is among 18 states and the District of Columbia that accept mailed ballots received after Election Day as long they are postmarked on or before that date, according to the National Conference of State Legislatures. In March, Trump signed a sweeping executive order on elections that aims to require votes to be 'cast and received' by Election Day and says federal funding should be conditional on state compliance. In their appeal to the court, the Illinois Republicans said the justices should make clear that candidates have the right to challenge state regulations of federal elections.
Yahoo
3 days ago
- Business
- Yahoo
Tarrant County judge on redistricting: 'The mission is to get three Republican commissioners'
The Brief Tarrant County's redistricting plan is facing criticism for allegedly diluting the votes of non-White residents. County Judge Tim O'Hare openly states his goal is to guarantee three Republican commissioners on the court, increasing conservative leadership. Seven maps are currently under consideration before a vote on Tuesday, amid concerns about transparency and the use of outdated 2020 census data. TARRANT COUNTY, Texas - A plan to redistrict Tarrant County has recently come under fire after critics say it may be biased against non-White voters. County Judge Tim O'Hare isn't trying to hide his motive for redistricting: To further increase conservative leadership in Tarrant County by decreasing the number of Democrats in the commissioners court. O'Hare, the Republican county judge, presides over a panel that currently has two Republican and two Democrat commissioners. In his first one-on-one interview with FOX 4 since taking office, O'Hare welcomed us into his Southlake county courthouse office. What they're saying "On Tuesday I hope we pass a map that guarantees, or comes as close as you can to guarantee, three Republican commissioners," O'Hare said. "That was my plan and what I campaigned on openly and publicly, dating as far back as May 2021." He responded to critics who are opposed to his effort to redraw Tarrant's district lines, with allegations that his plan lacks transparency and sufficient public input, along with claims that it is racially discriminating and violates the federal voting rights act. "It's purely partisan. I'm not going to try to hide from that or act like it isn't. That's exactly what it is," O'Hare said. "We've had four different meetings in each precinct, we put maps online for anyone to look at and see and go over them. We've given people the opportunity to submit their own maps and weigh in with comments through the website, through emails, through the public forum, through commissioners court meetings… So, I don't know how anyone with a straight face can say this is not transparent." When asked if he believes the redistricting plan constitutes racial gerrymandering, O'Hare made his end goal clear. "At the end of the day, I'm doing it to put another Republican on the commissioners court, period, the end," the judge said. "I don't look at it in terms of race, I look at it in terms of policy. I look at it in terms of results," O'Hare went on. "The mission is to get three Republican commissioners on the commissioners court." O'Hare compared his redistricting effort to a reversal of what's happened over the years in several now majority-liberal counties. "I didn't see these people come out and complain about what Dallas, Harris, Bexar or Travis County was doing, but they're complaining about what we're doing because they don't want to lose seats, but we know if they were in charge because they did it in those counties, that's their blueprint, we know if they were in charge here they do the same thing," the judge said. There is also speculation that O'Hare's focus is aimed specifically at unseating District 2 Commissioner Alisa Simmons. The two have often sparred during meetings on a variety of topics. That said, the judge denies wanting to unseat the commissioner. "I campaigned on this issue dating as far back as 2021," O'Hare said. " At the time I did that, I had never heard her name, didn't know who she was, had picked her out of a lineup of one, so the answer to that is just simply 'no.'" Another concern from critics is whether the 2020 census data used to create the maps is too old. But the mayors who support the plan point out that Tarrant redistricting has been delayed even longer – nearly 15 years. O'Hare says there are now seven maps up for consideration before Tuesday's vote. "I believe Tarrant County would be better served if we have strong Republican leadership," said O'Hare. "Tarrant County voters have elected Republicans to every single countywide office dating back 30 years, but we have two to two when it comes to Republicans and Democrats on commissioners court. I think it should more accurately reflect our voting population, so I want to see it go three to one." The backstory SMU mathematics professor and researcher Dr. Andrea Barreiro has dissected and analyzed the newly proposed maps for Tarrant County districts, the work of a county-hired consulting firm and the public legal interest foundation. In an interview on Thursday, she said the goal of the redistricting appears to be to diminish the voting power of non-White county residents. Cities including Fort Worth, Arlington, Mansfield and Grand Prairie have signed a letter expressing their opposition to the proposed map. The group called the effort ill-timed because it's the middle of the decade and, in their opinion, the census data from 2020 is outdated. In early April, the commission voted three to two, with commissioners Alisa Simmons and Roderick Miles opposing, to approve a contract with the Public Interest Legal Foundation to provide consultation with re-drawing district lines. What's next Opponents of the plan have vowed to wage a legal battle if it's adopted. O'Hare said he believed that would go in his favor. The Source Information in this article came from Tarrant County Judge Tim O'Hare and previous FOX 4 reporting.
Washington Post
15-05-2025
- Politics
- Washington Post
Challengers argue Georgia's new maps still harm Black voters
ATLANTA — Challengers on Thursday told a federal appeals court that Georgia lawmakers are still violating Black voters' rights after redrawing the state's congressional and legislative maps. If judges uphold the challenges, they could order different district lines to be used in Georgia for the rest of the decade, making it possible that more districts would elect candidates favored by Black voters — usually Democrats.
Yahoo
12-05-2025
- Business
- Yahoo
Number of Shares and Voting Rights of Innate Pharma as of May 5, 2025
MARSEILLE, France, May 12, 2025--(BUSINESS WIRE)--Regulatory News: Pursuant to the article L. 233-8 II of the French "Code de Commerce" and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or "AMF") General Regulation, Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") releases its total number of shares outstanding as well as its voting rights as at May 5, 2025: Total number of shares outstanding: 92,176,373 ordinary shares 6,489 Preferred Shares 2016 7,581 Preferred Shares 2017 Total number of theoretical voting rights (1): Total number of exercisable voting rights (2): 92,962,943 92,944,368 (1) The total number of theoretical voting rights (or "gross" voting rights) is used as the basis for calculating the crossing of shareholding thresholds. In accordance with Article 223-11 of the AMF General Regulation, this number is calculated on the basis of all shares to which voting rights are attached, including shares whose voting rights have been suspended. The total number of theoretical voting rights includes voting rights attached to AGAP 2016, i.e. 130 voting rights for the AGAP 2016-1 and 111 voting rights for the AGAP 2016-2. No voting rights attached to AGAP 2017. (2) The total number of exercisable voting rights (or "net" voting rights) is calculated without taking into account the shares held in treasury by the Company, with suspended voting rights. It is released so as to ensure that the market is adequately informed, in accordance with the recommendation made by the AMF on July 17, 2007. About Innate Pharma Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Its innovative approach aims to harness the innate immune system through therapeutic antibodies and its ANKET® (Antibody-based NK cell Engager Therapeutics) proprietary platform. Innate's portfolio includes lead proprietary program lacutamab, developed in advanced form of cutaneous T cell lymphomas and peripheral T cell lymphomas, monalizumab developed with AstraZeneca in non-small cell lung cancer, as well as ANKET® multi-specific NK cell engagers to address multiple tumor types. Innate Pharma is a trusted partner to biopharmaceutical companies such as Sanofi and AstraZeneca, as well as leading research institutions, to accelerate innovation, research and development for the benefit of patients. Headquartered in Marseille, France with a US office in Rockville, MD, Innate Pharma is listed on Euronext Paris and Nasdaq in the US. Learn more about Innate Pharma at and follow us on LinkedIn and X. Information about Innate Pharma shares ISIN code Ticker code LEI FR0010331421 Euronext: IPH Nasdaq: IPHA 9695002Y8420ZB8HJE29 Disclaimer on forward-looking information and risk factors This press release contains certain forward-looking statements, including those within the meaning of the Private Securities Litigation Reform Act of 1995. The use of certain words, including "believe," "potential," "expect" and "will" and similar expressions, is intended to identify forward-looking statements. Although the company believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated. These risks and uncertainties include, among other things, the uncertainties inherent in research and development, including related to safety, progression of and results from its ongoing and planned clinical trials and preclinical studies, review and approvals by regulatory authorities of its product candidates, the Company's commercialization efforts and the Company's continued ability to raise capital to fund its development. For an additional discussion of risks and uncertainties which could cause the company's actual results, financial condition, performance or achievements to differ from those contained in the forward-looking statements, please refer to the Risk Factors ("Facteurs de Risque") section of the Universal Registration Document filed with the French Financial Markets Authority ("AMF"), which is available on the AMF website or on Innate Pharma's website, and public filings and reports filed with the U.S. Securities and Exchange Commission ("SEC"), including the Company's Annual Report on Form 20-F for the year ended December 31, 2023, and subsequent filings and reports filed with the AMF or SEC, or otherwise made public, by the Company. This press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to shares in Innate Pharma in any country. View source version on Contacts For additional information, please contact:Investors Innate Pharma Henry WheelerTel.: +33 (0)4 84 90 32 Media Relations NewCap Arthur RouilléTel.: +33 (0)1 44 71 00 15innate@
